My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$RTN {{ '2015-12-10T13:17:17+0000' | timeago}} • Announcement

Defense company $RTN said it has secured a $29.6MM contract from the US Air Force to install MXF-626K VHF Communications Systems on 178 C-130H Hercules aircraft. This upgrade ensures compliance of C-130 radios with newly adopted European Air Traffic Management requirements and is a designed form/fit and functional replacement for the ARC-186 radio.

User Vishnu Beri {{ '2016-10-25T21:15:45+0000' | timeago}}

Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.

User Mark Collas {{ '2016-10-25T20:12:01+0000' | timeago}}

Waiting with fingers crossed for $AAPL’s fourth quarter earnings.

User RC xNair {{ '2016-10-25T17:04:47+0000' | timeago}}

Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."

User Carlton Davis {{ '2016-10-24T19:31:20+0000' | timeago}}

$COL agreed to buy $BEAV for $6.4 billion in cash and stock. Also Rockwell Collins reported higher 4Q16 earnings on growth in Government Systems and higher revenue in Information Management Services.

User Charles Elliston {{ '2016-10-24T19:15:21+0000' | timeago}}

Wow! What a buzz the $T-$TWX deal is making! Almost everyone from politicians to competitors have come out against this deal. Even Wall Street doesn’t seem to be too thrilled. Both stocks were down today.

$CMCSA {{ '2016-10-26T13:09:05+0000' | timeago}} • Webcast

In 3Q16, $CMCSA’s Cable Networks revenue increased 22% to $2.9Bil, including $432MM of revenue associated with the Rio Olympics. Broadcast Television revenue increased 56.6% to $3.1Bil. Filmed Entertainment revenue declined 7.9% to $1.8Bil. Theme Parks revenue increased 60.6% to $1.4Bil in 3Q16.

$NSC {{ '2016-10-26T13:08:03+0000' | timeago}} • Announcement

$NSC's general merchandise revenues for 3Q16 declined by 4% from the previous year quarter. Volume declined 4%, due to fewer crude oil, vehicles, pulpboard and feed market shipments. Revenue declined in three of its five business groups.

$NSC {{ '2016-10-26T13:04:51+0000' | timeago}} • Announcement

Railroad operator $NSC reported a 2% rise in 3Q16 earnings driven by lower costs and expenses as well as a decline in provision for income taxes. Net income slid to $460MM or $1.55 per share from $452MM or $1.49 per share last year. Total railway operating revenues fell 7% to $2.52Bil on reduced volumes and lower fuel surcharge revenues.

$CMCSA {{ '2016-10-26T13:02:56+0000' | timeago}} • Webcast

$CMCSA said high-speed Internet revenue increased 8.8% in 3Q16. Video revenue increased 4.5% and business services revenue increased 15.5%. Other revenue increased 13%. Advertising revenue increased 7.7%, reflecting an increase in political advertising revenue.

$BIIB {{ '2016-10-26T12:55:26+0000' | timeago}} • Webcast

$BIIB's 3Q16 hemophilia revenues grew to $217MM. In Europe, the company has doubled its biosimilars revenues over the prior quarter, as BENEPALI continues to launch in markets across the continent and pick up share at a rate previously unseen for a biosimilar anti-TNF. A biosimilar of infliximab, FLIXABI was also launched.